CLG LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Buy
+359
New +$367K 0.09% 107
2026
Q1
Sell
-249
Closed -$268K 143
2025
Q4
$268K Sell
249
-55
-18% -$52.6K 0.07% 119
2025
Q3
$232K Buy
304
+23
+8% +$17.1K 0.06% 125
2025
Q2
$219K Buy
281
+32
+13% +$24.9K 0.07% 120
2025
Q1
$205K Buy
+249
New +$207K 0.07% 117

Other funds holding LLY

CLG LLC's LLY Position: Q2 2026 in Review

CLG LLC opened a new position in Eli Lilly (LLY) in Q2 2026: 359 shares worth $431K. The stake represents 0.09% of the portfolio and ranks #107 among its holdings. This is a return to the name: CLG LLC previously reported a position in LLY as recently as Q4 2025.

CLG LLC first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CLG LLC held 359 shares of Eli Lilly worth $431K as of Q2 2026.
  • Eli Lilly was a new CLG LLC position in Q2 2026.
  • Eli Lilly made up 0.09% of CLG LLC's portfolio in Q2 2026, its #107 holding.
  • CLG LLC first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CLG LLC's 13F filing for Q2 2026, filed 16 Jul 2026.